Menu
Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ
History
Inhibition of AP-1 tra
Tumor Microvessel Dens
See All (2) pages
Keywords
Last Name
Institution
@uada.edu
@ualr.edu
@uapb.edu
@uark.edu
University of Arkansas for Medical Sciences
More Search Options
Announcement
You can now add alternative names!
Click here
to add other names that you've published under.
Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses.
Bais C, Mueller B, Brady MF, Mannel RS, Burger RA, Wei W, Marien KM, Kockx MM, Husain A, Birrer MJ. Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses. J Natl Cancer Inst. 2017 11 01; 109(11).
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Angiogenesis Inhibitors
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Confidence Intervals
Disease-Free Survival
Double-Blind Method
Drug Administration Schedule
Female
Humans
Intention to Treat Analysis
Microvessels
Middle Aged
Neuropilin-1
Ovarian Neoplasms
Paclitaxel
Proto-Oncogene Proteins c-met
Retrospective Studies
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factor Receptor-2
authors with profiles
Michael Birrer